CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Beximco Pharmaceuticals Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Beximco Pharmaceuticals Ltd
19 Dhanmondi R/A, Road No. 7
Phone: +880 258611001p:+880 258611001 DHAKA, 1205  Bangladesh Ticker: BXPHARMABXPHARMA
Business Summary
Beximco Pharmaceuticals Limited is a Bangladesh-based company which is a manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The Company is engaged in manufacturing and marketing of generic pharmaceutical formulation products covering a range of therapeutic categories. It offers products in different dosage forms, including Solid, Liquid, Cream and Ointment, Suppositories, Metered Dose Inhaler, Dry Powder Inhaler, Nasal Spray, Sterile, Lyophilized Injectable and Large Volume Intravenous Fluids. Besides formulation products, the Company also manufactures APIs and renders contract manufacturing services to other companies. Products of the Company are sold in domestic and international markets. The subsidiaries of the Company include Nuvista Pharma Limited (NPL), Synovia Pharma PLC (SPP), Beximco Pharma API Limited (BPAL).

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20246/30/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Ahmed S.Rahman
Vice Chairman of the Board Ahmed S.Rahman
Chief Financial Officer Mohammad AliNawaz 1/1/2003
12 additional Officers and Directors records available in full report.

Business Names
Business Name
Beximco Pharma API Ltd.
Beximco Pharmaceuticals Limited
BXMPY
5 additional Business Names available in full report.

General Information
Number of Employees: 1,122 (As of 6/30/2024)
Outstanding Shares: 446,112,089 (As of 9/30/2024)
Shareholders: 48,217
Stock Exchange: DSE
Fax Number: +880 258613888


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024